Humana's Re-Balancing Act

Is Medicare turning into a bad business for Humana? That surprising question may dog the company heading into 2007-and the answer may be pivotal to the viability of the private insurance-based drug benefit.

Humana Inc.’s dramatic expansion under Medicare has fueled enormous growth at the company, with revenues for the third quarter jumping nearly 50% to $5.65 billion, thanks to soaring membership in Humana’s Medicare Advantage managed care plans—and the more than 3.5 million enrollees in Humana’s brand new stand-alone prescription drug business.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Market Access

More from Pink Sheet